Integrated
Annual Report 2016

Notes to the Consolidated Financial Statements

1. Basic information and principles of the report

2. Changes in Group structure

3. Summary of significant accounting policies

4. Risk assessment and management

5. Management of capital

6. Trade accounts receivable

7. Other current assets and current financial assets

8. Inventories

9. Property, plant and equipment

10. Other non-current assets and non-current financial assets

11. Goodwill and intangible assets

12. Short-term debt

13. Other current liabilities and provisions

14. Long-term debt

15. Financial instruments

16. Retirement benefit plans

17. Participation plans

18. Deferred tax assets and liabilities

19. Other non-current liabilities and provisions

20. Contingencies

21. Capital stock and treasury shares

22. Earnings per share

23. Other operating expenses, net

24. Financial result, net

25. Income tax expenses

26. Operating Leasing

27. Research and development cost

  2016 2015
  MCHF MCHF
Research and development expenses 72.3 63.4
Capitalised development expenses -5.7 -7.8
Amortisation of capitalised development expenses 2.1 1.1
Research and development cost 68.7 56.7

Geberit spent in the past in av­er­age around 2.4% of net sales on re­search and de­vel­op­ment every year (2016: 2.6%). The ex­penses have re­mained rel­a­tively con­stant over the years. In 2016, re­search and de­vel­op­ment ex­penses to­talling MCHF 72.3 (PY: MCHF 63.4) were in­cluded in the items “Per­son­nel ex­penses”, “De­pre­ci­a­tion” and “Other op­er­at­ing ex­penses, net”. For four major de­vel­op­ment pro­jects, the cap­i­tal­i­sa­tion cri­te­ria ac­cord­ing to IAS 38.57 were met and ex­penses of MCHF 5.7 (PY: MCHF 7.8) were cap­i­talised.

28. Cashflow figures

29. Segment reporting

30. Related party transactions

31. Foreign exchange rates

32. Subsequent events

33. Group companies as of December 31, 2016